• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

优化基于微球的凝胶中克林霉素的包封效率和释放。

Optimization of entrapment efficiency and release of clindamycin in microsponge based gel.

机构信息

Faculty of Pharmacy, Damascus University, Damascus, Syria.

出版信息

Sci Rep. 2021 Dec 2;11(1):23345. doi: 10.1038/s41598-021-02826-7.

DOI:10.1038/s41598-021-02826-7
PMID:34857863
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8639917/
Abstract

The aim of the present study was to formulate clindamycin (CLN) as a microsponge based gel to release the drug in a controlled manner and reduce the side effects in the treatment of acne. Since this method requires poor water solubility of the drug to be loaded in particles, therefore, conversion of the hydrochloride salt to free base was done. By using an emulsion solvent diffusion method, we made six different formulations of microsponges containing CLN-free base by changing the proportions of polymer, emulsifier and the pH of the external phase. These formulations were studied for physical characterization and for drug- polymer interactions. The physical characterization showed that microsponge formulations coded by C5, C6 resulted in a better loading efficiency and production yield and their particle size was less than 30 µm. Scanning electron microscopy images showed the microsponges porous and spherical. C5, C6 microsponge formulation was prepared as gel in Carbopol and in vitro evaluated. The microsponge formulation gel C8 was found to be optimized. C8 released 90.38% of drug over 12 h and showed viscosity 20,157 ± 38 cp, pH of 6.3 ± 0.09 and drug content of 99.64 ± 0.04%. Fourier transform infrared spectroscopy and differential scanning calorimetry confirmed no significant interactions between excipients and drug.

摘要

本研究的目的是将克林霉素(CLN)制成微海绵凝胶,以控制药物释放并减少治疗痤疮的副作用。由于该方法需要将药物的低水溶性负载到颗粒中,因此将盐酸盐转化为游离碱。我们使用乳化溶剂扩散法,通过改变聚合物、乳化剂和外相 pH 的比例,制备了六种不同载有 CLN 游离碱的微海绵配方。这些配方进行了物理特性研究和药物-聚合物相互作用研究。物理特性研究表明,编码为 C5 和 C6 的微海绵配方具有更好的载药效率和产率,且粒径小于 30µm。扫描电子显微镜图像显示微海绵具有多孔和球形结构。C5 和 C6 微海绵配方被制备成 Carbopol 凝胶并进行了体外评估。发现微海绵配方凝胶 C8 是优化的。C8 在 12 小时内释放了 90.38%的药物,显示出粘度为 20,157±38cp、pH 值为 6.3±0.09 和药物含量为 99.64±0.04%。傅里叶变换红外光谱和差示扫描量热法证实赋形剂和药物之间没有明显的相互作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dc4a/8639917/cb5ae826554f/41598_2021_2826_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dc4a/8639917/14a200521418/41598_2021_2826_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dc4a/8639917/42a93a2e54a8/41598_2021_2826_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dc4a/8639917/5210b7fcac6d/41598_2021_2826_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dc4a/8639917/deac008cc701/41598_2021_2826_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dc4a/8639917/cb5ae826554f/41598_2021_2826_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dc4a/8639917/14a200521418/41598_2021_2826_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dc4a/8639917/42a93a2e54a8/41598_2021_2826_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dc4a/8639917/5210b7fcac6d/41598_2021_2826_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dc4a/8639917/deac008cc701/41598_2021_2826_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dc4a/8639917/cb5ae826554f/41598_2021_2826_Fig5_HTML.jpg

相似文献

1
Optimization of entrapment efficiency and release of clindamycin in microsponge based gel.优化基于微球的凝胶中克林霉素的包封效率和释放。
Sci Rep. 2021 Dec 2;11(1):23345. doi: 10.1038/s41598-021-02826-7.
2
Microsponge based gel as a simple and valuable strategy for formulating and releasing Tazarotene in a controlled manner.基于微海绵的凝胶作为一种简单而有价值的策略,可用于以受控的方式配制和释放他扎罗汀。
Sci Rep. 2022 Jul 6;12(1):11414. doi: 10.1038/s41598-022-15655-z.
3
Formulation and development of herbal microsponge sunscreen gel.中草药微囊防晒啫喱的制备与研制。
J Cosmet Dermatol. 2022 Apr;21(4):1675-1687. doi: 10.1111/jocd.14274. Epub 2021 Jun 23.
4
Nebivolol-Loaded Microsponge Gel for Healing of Diabetic Wound.载比索洛尔的微海绵凝胶促进糖尿病伤口愈合。
AAPS PharmSciTech. 2017 Apr;18(3):846-854. doi: 10.1208/s12249-016-0574-3. Epub 2016 Jun 29.
5
Development and evaluation of xanthan gum-facilitated ethyl cellulose microsponges for controlled percutaneous delivery of diclofenac sodium.黄原胶促进的乙基纤维素微球的制备及其用于双氯芬酸钠经皮控释的评价。
Acta Pharm. 2011 Sep 1;61(3):257-70. doi: 10.2478/v10007-011-0022-6.
6
The microsponge delivery system of benzoyl peroxide: preparation, characterization and release studies.过氧化苯甲酰的微海绵递送系统:制备、表征及释放研究。
Int J Pharm. 2006 Feb 3;308(1-2):124-32. doi: 10.1016/j.ijpharm.2005.11.001. Epub 2005 Dec 15.
7
Fabrication, characterization, and evaluation of microsponge delivery system for facilitated fungal therapy.用于促进真菌治疗的微球递送系统的制备、表征及评价
J Basic Clin Pharm. 2016 Mar;7(2):39-48. doi: 10.4103/0976-0105.177705.
8
Formulation and In Vitro Evaluation of a Ramipril Entrapped in a Microsponge-based Drug-delivery System.基于微球的药物递送系统包载雷米普利的制剂及其体外评价
Int J Pharm Compd. 2023 Jul-Aug;27(4):340-346.
9
Formulation and optimization of microsponge-loaded emulgel to improve the transdermal application of acyclovir-a DOE based approach.微海绵载乳凝胶的配方优化,以改善阿昔洛韦的经皮应用——基于 DOE 的方法。
Drug Deliv Transl Res. 2021 Oct;11(5):2009-2029. doi: 10.1007/s13346-020-00862-w. Epub 2020 Nov 6.
10
Resveratrol-Loaded Microsponge Gel for Wound Healing: and Characterization.用于伤口愈合的白藜芦醇微海绵凝胶:表征
Turk J Pharm Sci. 2023 Mar 2;20(1):23-34. doi: 10.4274/tjps.galenos.2022.93275.

引用本文的文献

1
Synthesis of polymer-clindamycin conjugates through lipase-catalyzed esterification and RAFT polymerization.通过脂肪酶催化酯化和可逆加成-断裂链转移(RAFT)聚合合成聚合物-克林霉素缀合物。
Polymer (Guildf). 2025 Jan 15;317. doi: 10.1016/j.polymer.2024.127965. Epub 2024 Dec 18.
2
Enhancing skin residence time of penciclovir for the treatment of cold sores: formulation and characterization of controlled release microsponges.提高喷昔洛韦在皮肤的停留时间以治疗唇疱疹:控释微海绵的制剂与表征
Naunyn Schmiedebergs Arch Pharmacol. 2025 Aug 8. doi: 10.1007/s00210-025-04506-z.
3
Microscale Delivery Systems for Hydrophilic Active Ingredients in Functional Consumer Goods.

本文引用的文献

1
Clindamycin as an Alternative Option in Optimizing Periodontal Therapy.克林霉素作为优化牙周治疗的替代选择。
Antibiotics (Basel). 2021 Jul 4;10(7):814. doi: 10.3390/antibiotics10070814.
2
Design and characterization of clindamycin-loaded nanofiber patches composed of polyvinyl alcohol and tamarind seed gum and fabricated by electrohydrodynamic atomization.由聚乙烯醇和罗望子种子胶组成并通过电液动力雾化制备的载有克林霉素的纳米纤维贴片的设计与表征。
Asian J Pharm Sci. 2018 Sep;13(5):450-458. doi: 10.1016/j.ajps.2018.01.002. Epub 2018 Jan 31.
3
Application of salt engineering to reduce/mask bitter taste of clindamycin.
功能性消费品中亲水性活性成分的微尺度递送系统
Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2025 Mar-Apr;17(2):e70009. doi: 10.1002/wnan.70009.
4
Formulation and Evaluation of Microsponges-loaded Transdermal Gel for the Management of Osteoarthritis.用于骨关节炎治疗的载微海绵透皮凝胶的制剂与评价
Recent Adv Inflamm Allergy Drug Discov. 2025;19(1):79-99. doi: 10.2174/0127722708297654240718053117.
5
Multidimensional opioid abuse deterrence using a nanoparticle-polymer hybrid formulation.使用纳米颗粒-聚合物杂化配方进行多维阿片类药物滥用防治。
J Control Release. 2024 Jun;370:490-500. doi: 10.1016/j.jconrel.2024.04.046. Epub 2024 May 8.
6
Targeted Clindamycin Delivery Systems: Promising Options for Preventing and Treating Bacterial Infections Using Biomaterials.靶向克林霉素递送系统:使用生物材料预防和治疗细菌感染的有前景的选择。
Int J Mol Sci. 2024 Apr 16;25(8):4386. doi: 10.3390/ijms25084386.
7
Key Fabrications of Chitosan Nanoparticles for Effective Drug Delivery Using Flow Chemistry Reactors.采用流动化学反应器有效药物输送的壳聚糖纳米颗粒的关键构建。
Int J Nanomedicine. 2023 Dec 21;18:7889-7900. doi: 10.2147/IJN.S433756. eCollection 2023.
8
Understanding the Effects of Associated Factors in the Development of Microsponge-Based Drug Delivery: a Statistical Quality by Design (QbD) Approach Towards Optimization.理解影响基于微球的药物传递系统发展的相关因素:一种面向优化的基于统计质量设计(QbD)方法。
AAPS PharmSciTech. 2022 Sep 16;23(7):256. doi: 10.1208/s12249-022-02409-3.
9
Microsponge based gel as a simple and valuable strategy for formulating and releasing Tazarotene in a controlled manner.基于微海绵的凝胶作为一种简单而有价值的策略,可用于以受控的方式配制和释放他扎罗汀。
Sci Rep. 2022 Jul 6;12(1):11414. doi: 10.1038/s41598-022-15655-z.
10
Ammonio Methacrylate Copolymer (Type B)-Diltiazem Interactions in Solid Dispersions and Drug-Delivery Systems.固体分散体和药物递送系统中甲基丙烯酸铵共聚物(B型)与地尔硫䓬的相互作用
Polymers (Basel). 2022 May 23;14(10):2125. doi: 10.3390/polym14102125.
盐工程在减少/掩盖克林霉素苦味中的应用。
Drug Dev Ind Pharm. 2019 Dec;45(12):1871-1878. doi: 10.1080/03639045.2019.1672715. Epub 2019 Oct 18.
4
Dendrimer entrapped microsponge gel of dithranol for effective topical treatment.用于有效局部治疗的二羟基蒽醌包封于树枝状聚合物中的微海绵凝胶
Heliyon. 2019 Mar 20;5(3):e01343. doi: 10.1016/j.heliyon.2019.e01343. eCollection 2019 Mar.
5
Microsponge: An emerging drug delivery strategy.微海绵:一种新兴的药物传递策略。
Drug Dev Res. 2019 Mar;80(2):200-208. doi: 10.1002/ddr.21492. Epub 2018 Nov 19.
6
Ocular administration of acetazolamide microsponges in situ gel formulations.乙酰唑胺微海绵原位凝胶制剂的眼部给药。
Saudi Pharm J. 2018 Nov;26(7):909-920. doi: 10.1016/j.jsps.2018.01.005. Epub 2018 Sep 24.
7
Nanotechnological Advances for Cutaneous Release of Tretinoin: An Approach to Minimize Side Effects and Improve Therapeutic Efficacy.纳米技术在维 A 酸经皮释放中的进展:减少副作用和提高治疗效果的一种方法。
Curr Med Chem. 2018;25(31):3703-3718. doi: 10.2174/0929867325666180313110917.
8
Improved vaginal retention and enhanced antifungal activity of miconazole microsponges gel: Formulation development and in vivo therapeutic efficacy in rats.米康唑微球凝胶提高阴道保留率和增强抗真菌活性:制剂开发及在大鼠体内的治疗效果。
Eur J Pharm Sci. 2018 Mar 1;114:255-266. doi: 10.1016/j.ejps.2017.12.023. Epub 2017 Dec 28.
9
Eudragit S100 coated microsponges for Colon targeting of prednisolone.Eudragit S100 包衣的载药微海绵用于醋酸泼尼松龙结肠靶向给药。
Drug Dev Ind Pharm. 2018 Jun;44(6):902-913. doi: 10.1080/03639045.2017.1420079. Epub 2018 Jan 3.
10
Investigation of Drug-Polymer Compatibility Using Chemometric-Assisted UV-Spectrophotometry.采用化学计量学辅助紫外分光光度法研究药物-聚合物相容性
Pharmaceutics. 2017 Jan 16;9(1):7. doi: 10.3390/pharmaceutics9010007.